FULGENT GENETICS, INC. Tax Withholding Paid on Stock Awards
FULGENT GENETICS, INC. (FLGT) reported Tax Withholding Paid on Stock Awards of $4.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-30.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-07-30
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $334.00K, a 3.19% decline year-over-year.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $4.20M, a 122.58% increase year-over-year.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $447.00K, a 84.71% increase year-over-year.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $357.00K, a 17.17% decline year-over-year.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $3.04M, a 4.73% increase from fiscal 2024.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $2.90M, a 6.11% increase from fiscal 2023.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2023 was $2.73M, a 54.52% increase from fiscal 2022.
- FULGENT GENETICS, INC. payment, tax withholding, share-based payment arrangement for fiscal 2022 was $1.77M, a 57.45% decline from fiscal 2021.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $334.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $4.53M 10-Q · filed 2026-07-30 | $4.98M derived: sum of 3 quarters · filed 2026-07-30 | $5.34M derived: sum of 4 quarters · filed 2026-07-30 |
| 2026-03-31 | $4.20M 10-Q · filed 2026-05-01 | $4.65M derived: sum of 2 quarters · filed 2026-05-01 | $5.00M derived: sum of 3 quarters · filed 2026-05-01 | $5.35M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-12-31 | $447.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $804.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.15M derived: sum of 3 quarters · filed 2026-07-30 | $3.04M 10-K · filed 2026-02-27 |
| 2025-09-30 | $357.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $702.00K derived: sum of 2 quarters · filed 2026-07-30 | $2.59M 10-Q · filed 2025-11-07 | $2.83M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-06-30 | $345.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-30 | $2.23M 10-Q · filed 2026-07-30 | $2.47M derived: sum of 3 quarters · filed 2026-07-30 | $2.90M derived: sum of 4 quarters · filed 2026-07-30 |
| 2025-03-31 | $1.89M 10-Q · filed 2026-05-01 | $2.13M derived: sum of 2 quarters · filed 2026-05-01 | $2.56M derived: sum of 3 quarters · filed 2026-05-01 | $3.10M derived: sum of 4 quarters · filed 2026-05-01 |
| 2024-12-31 | $242.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $673.00K derived: sum of 2 quarters · filed 2026-02-27 | $1.22M derived: sum of 3 quarters · filed 2026-02-27 | $2.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | $431.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $975.00K derived: sum of 2 quarters · filed 2025-11-07 | $2.66M 10-Q · filed 2025-11-07 | $3.77M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $544.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-01 | $2.23M 10-Q · filed 2025-08-01 | $3.34M derived: sum of 3 quarters · filed 2026-02-27 | $3.86M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $1.68M 10-Q · filed 2025-05-02 | $2.80M derived: sum of 2 quarters · filed 2026-02-27 | $3.31M derived: sum of 3 quarters · filed 2026-02-27 | $3.54M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $1.11M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $1.63M derived: sum of 2 quarters · filed 2026-02-27 | $1.86M derived: sum of 3 quarters · filed 2026-02-27 | $2.73M 10-K · filed 2026-02-27 |
| 2023-09-30 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $749.00K derived: sum of 2 quarters · filed 2024-11-08 | $1.62M 10-Q · filed 2024-11-08 | $1.93M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-06-30 | $232.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.10M 10-Q · filed 2024-08-02 | $1.42M derived: sum of 3 quarters · filed 2025-02-28 | $1.94M derived: sum of 4 quarters · filed 2025-02-28 |
| 2023-03-31 | $869.00K 10-Q · filed 2024-05-03 | $1.19M derived: sum of 2 quarters · filed 2025-02-28 | $1.71M derived: sum of 3 quarters · filed 2025-02-28 | $2.14M derived: sum of 4 quarters · filed 2025-02-28 |
| 2022-12-31 | $316.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $838.00K derived: sum of 2 quarters · filed 2025-02-28 | $1.27M derived: sum of 3 quarters · filed 2025-02-28 | $1.77M 10-K · filed 2025-02-28 |
| 2022-09-30 | $522.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03 | $958.00K derived: sum of 2 quarters · filed 2023-11-03 | $1.45M 10-Q · filed 2023-11-03 | $2.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $436.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $930.00K 10-Q · filed 2023-08-04 | $1.62M derived: sum of 3 quarters · filed 2024-02-28 | $4.53M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | $494.00K 10-Q · filed 2023-05-05 | $1.18M derived: sum of 2 quarters · filed 2024-02-28 | $4.10M derived: sum of 3 quarters · filed 2024-02-28 | $4.14M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $688.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $3.60M derived: sum of 2 quarters · filed 2024-02-28 | $3.64M derived: sum of 3 quarters · filed 2024-02-28 | $4.16M 10-K · filed 2024-02-28 |
| 2021-09-30 | $2.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | $2.95M derived: sum of 2 quarters · filed 2022-11-07 | $3.47M 10-Q · filed 2022-11-07 | $3.48M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | $39.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $552.00K 10-Q · filed 2022-08-04 | $568.00K derived: sum of 3 quarters · filed 2023-02-28 | $568.00K derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | $513.00K 10-Q · filed 2022-05-05 | $529.00K derived: sum of 2 quarters · filed 2023-02-28 | $529.00K derived: sum of 3 quarters · filed 2023-02-28 | |
| 2020-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $16.00K derived: sum of 2 quarters · filed 2023-02-28 | $62.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $46.00K 10-Q · filed 2021-11-09 | ||
| 2020-06-30 | $46.00K 10-Q · filed 2021-08-10 | |||
| 2019-12-31 | $21.00K 10-K · filed 2022-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |